These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7423440)

  • 1. Lipid activation of coagulation factor III apoprotein (tissue factor)--reconstitution of the protein-membrane complex.
    Carson SD; Konigsberg WH
    Thromb Haemost; 1980 Aug; 44(1):12-5. PubMed ID: 7423440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation factor III (tissue factor) interaction with phospholipid vesicles induced by cadmium: characterization of the reconstituted protein-membrane complex.
    Carson SD; Konigsberg WH
    Biosci Rep; 1981 Mar; 1(3):197-205. PubMed ID: 7295892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadmium increases tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids.
    Carson SD; Konigsberg WH
    Science; 1980 Apr; 208(4441):307-9. PubMed ID: 7367861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of thromboplastin apoprotein of different tissues with concanavalin A--evidence for heterogeneous glycosylation of the human apoprotein.
    van den Besselaar AM; Bertina RM
    Thromb Haemost; 1984 Oct; 52(2):192-5. PubMed ID: 6441304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity.
    Freyssinet JM; Brami B; Gauchy J; Cazenave JP
    Thromb Haemost; 1986 Feb; 55(1):112-8. PubMed ID: 3010487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.
    Bom VJ; Bertina RM
    Biochem J; 1990 Jan; 265(2):327-36. PubMed ID: 2302175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadmium causes vesicle leakage under conditions which favor reconstitution of tissue factor-vesicle complexes.
    Carson SD
    J Membr Biol; 1983 Jul; 75(2):123-7. PubMed ID: 25691372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of the protein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and X.
    Bjorklid E; Storm E; Osterud B; Prydz H
    Scand J Haematol; 1975 Mar; 14(1):65-70. PubMed ID: 1121648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of phospholipid scramblase activity from human blood platelets.
    Comfurius P; Williamson P; Smeets EF; Schlegel RA; Bevers EM; Zwaal RF
    Biochemistry; 1996 Jun; 35(24):7631-4. PubMed ID: 8672463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding kinetics of an alpha helical membrane protein in phospholipid bilayer vesicles.
    Allen SJ; Curran AR; Templer RH; Meijberg W; Booth PJ
    J Mol Biol; 2004 Sep; 342(4):1279-91. PubMed ID: 15351651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.